These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 14559815)

  • 1. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
    Noda K; Miyoshi E; Uozumi N; Yanagidani S; Ikeda Y; Gao C; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Hayashi N; Hori M; Taniguchi N
    Hepatology; 1998 Oct; 28(4):944-52. PubMed ID: 9755230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
    Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
    Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression of GDP-L-fucose-synthesizing enzymes, GDP-fucose transporter and fucosyltransferase VII.
    Niittymäki J; Mattila P; Renkonen R
    APMIS; 2006; 114(7-8):539-48. PubMed ID: 16907860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice.
    Miyoshi E; Noda K; Ko JH; Ekuni A; Kitada T; Uozumi N; Ikeda Y; Matsuura N; Sasaki Y; Hayashi N; Hori M; Taniguchi N
    Cancer Res; 1999 May; 59(9):2237-43. PubMed ID: 10232614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
    Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
    Huang LR; Hsu HC
    Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
    Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
    Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of the catalytic domain from rat hepatoma H35 cell GDP-fucose:GM1 alpha 1-->2fucosyltransferase, an enzyme which is activated during early stages of chemical carcinogenesis in rat liver.
    Sherwood AL; Holmes EH
    Arch Biochem Biophys; 1998 Jul; 355(2):215-21. PubMed ID: 9675030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
    Nakagawa T; Moriwaki K; Terao N; Nakagawa T; Miyamoto Y; Kamada Y; Miyoshi E
    J Proteome Res; 2012 May; 11(5):2798-806. PubMed ID: 22483194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
    Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
    J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.